申请人:Daun Jane
公开号:US20050124649A1
公开(公告)日:2005-06-09
The present invention provides compounds having formula (I), wherein R
1
, R
2
, R
3
and n are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of inflammatory or autoimmune and proliferative disorders and as inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction generally.
本发明提供具有公式(I)的化合物,其中R1、R2、R3和n如此处一般和分类子中所述,并且另外提供其制药组合物,以及在治疗炎症或自身免疫和增殖性疾病以及一般作为细胞黏附分子表达抑制剂和炎症细胞因子信号转导抑制剂的用途的方法。